Literature DB >> 11730996

Parotid and submandibular/sublingual salivary flow during high dose radiotherapy.

F R Burlage1, R P Coppes, H Meertens, M A Stokman, A Vissink.   

Abstract

It was studied whether differences in acute radiosensitivity exist between parotid and submandibular/sublingual glands. The results revealed that salivary flow rates decreased dramatically during the first 2 weeks of radiotherapy. Neither recovery nor significant differences were observed between the production of saliva from the parotid and submandibular/sublingual glands during the 13 weeks observation period.

Mesh：

Year:  2001        PMID： 11730996     DOI： 10.1016/s0167-8140(01)00427-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  45 in total

1.  Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.

Authors:  Jeremias Hey; Juergen Setz; Reinhard Gerlach; Martin Janich; Guido Hildebrandt; Dirk Vordermark; Christian R Gernhardt; Thomas Kuhnt
Journal:  Radiat Oncol       Date:  2011-09-27       Impact factor: 3.481

Review 2.  Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.

Authors:  Arjan Vissink; James B Mitchell; Bruce J Baum; Kirsten H Limesand; Siri Beier Jensen; Philip C Fox; Linda S Elting; Johannes A Langendijk; Robert P Coppes; Mary E Reyland
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-15       Impact factor: 7.038

Review 3.  The effect of radiotherapy on dental hard tissue--a systematic review.

Authors:  H F J Lieshout; C P Bots
Journal:  Clin Oral Investig       Date:  2013-07-20       Impact factor: 3.573

4.  Histamine modulates salivary secretion and diminishes the progression of periodontal disease in rat experimental periodontitis.

Authors:  Juan P Prestifilippo; Eliana Carabajal; Máximo Croci; Javier Fernández-Solari; Elena S Rivera; Juan C Elverdin; Vanina A Medina
Journal:  Inflamm Res       Date:  2012-01-20       Impact factor: 4.575

Review 5.  Intensive nutritional care for patients treated with radiotherapy in head and neck cancer: a randomized study and meta-analysis.

Authors:  Lise-Marie Roussel; Emmanuel Micault; Damien Peyronnet; David Blanchard; Séverine Guarnieri; Olivier Choussy; Bernard Géry; Arnaud Béquignon; Corinne Joubert; Jean-Jacques Parienti; Emmanuel Babin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-27       Impact factor: 2.503

6.  The influence of parotid gland sparing on radiation damages of dental hard tissues.

Authors:  Jeremias Hey; Johannes Seidel; Ramona Schweyen; Yvonne Paelecke-Habermann; Dirk Vordermark; Christian Gernhardt; Thomas Kuhnt
Journal:  Clin Oral Investig       Date:  2012-10-05       Impact factor: 3.573

7.  Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?

Authors:  Daan Nevens; Sandra Nuyts
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

Review 8.  [Radiation-related caries: etiology and possible preventive strategies. What should the radiotherapist know?].

Authors:  R Schweyen; J Hey; W Fränzel; D Vordermark; G Hildebrandt; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

9.  Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose.

Authors:  Kyle Wang; Kevin A Pearlstein; Dominic H Moon; Zahra M Mahbooba; Allison M Deal; Yue Wang; Stephanie R Sutton; Britni B Motley; Gregory D Judy; Jordan A Holmes; Nathan C Sheets; Mohit S Kasibhatla; Heather D Pacholke; Colette J Shen; Timothy M Zagar; Lawrence B Marks; Bhishamjit S Chera
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

10.  Loss of TRPM2 function protects against irradiation-induced salivary gland dysfunction.

Authors:  Xibao Liu; Ana Cotrim; Leyla Teos; Changyu Zheng; William Swaim; James Mitchell; Yasuo Mori; Indu Ambudkar
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.